
Join to view full profile
55 North Lake AveWorcester, MA 01655
Phone+1 508-334-3550
Dr. Holstead is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Ryan Holstead is an oncologist based in Worcester, MA, specializing in gastrointestinal and thoracic cancers. He completed a medical oncology fellowship at Queen's University after internal medicine residency at Zucker School of Medicine at Hofstra/Northwell. He graduated from SUNY Upstate Medical University in 2016. Dr. Holstead currently serves as an Assistant Professor at UMass Memorial Medical Center and previously held positions at Lenox Hill Hospital, The Mount Sinai Hospital, and North Shore Hematology - Oncology Associates. His research publications include articles on patient communication in oncology and immune checkpoint inhibitors, with several works published in prominent journals and a podcast on medical oncology.
Education & Training
Queen's UniversityFellowship in Medical Oncology, 2019 - 2021
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 2016 - 2019
SUNY Upstate Medical UniversityClass of 2016
Certifications & Licensure
MA State Medical License 2023 - 2027
NY State Medical License 2018 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology- Royal College of Physicians and Surgeons of CanadaInternal Medicine
Publications & Presentations
PubMed
- 4 citationsUtility of Large Language Models to Produce a Patient-Friendly Summary From Oncology Consultations.Ryan G Holstead
JCO Oncology Practice. 2024-09-01 - 8 citationsNo association between BMI and immunotoxicity or clinical outcomes for immune checkpoint inhibitors.Cynthia Yeung, Adi Kartolo, Ryan Holstead, Gordon Taylor Moffat, Lilian Hanna
Immunotherapy. 2022-07-01 - 5 citationsA Systematic Review and Meta-analysis of Dual Therapy in Patients With Advanced Renal Cell Carcinoma of Favourable RiskAdi Kartolo, Ryan Holstead, Ignacio Duran, Andrew G. Robinson, Francisco E. Vera-Badillo
Urology. 2021-08-28
Authored Content
- Talking About Tumors with Ryann and Ryan - A medical oncology podcastSeptember 2022
Professional Memberships
- Member
- Royal College of Physicians and Surgeons of CanadaFellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









